After FDA approval for children 6 and older, ADA data show inhaled insulin's safety and satisfaction benefits, but clinician awareness remains a key barrier.
Kevin Kaiserman, MD
Advertisement
Kevin Kaiserman, MD, is senior vice president and therapeutic area head for diabetes at MannKind Corporation.
Articles by Kevin Kaiserman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
2
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
3
First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA
4
Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery
5